JPH06508641A - 医薬組成物 - Google Patents

医薬組成物

Info

Publication number
JPH06508641A
JPH06508641A JP5518208A JP51820893A JPH06508641A JP H06508641 A JPH06508641 A JP H06508641A JP 5518208 A JP5518208 A JP 5518208A JP 51820893 A JP51820893 A JP 51820893A JP H06508641 A JPH06508641 A JP H06508641A
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition
composition according
alginic acid
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP5518208A
Other languages
English (en)
Japanese (ja)
Inventor
センツォバ，タティアナ　ニコラエフナ
ヤクボビチ，ビクトル　セメノビチ
ラスキナ，リュドミラ　パフロフナ
バラバノフ，バレリ　アレクサンドロビチ
イルチェンコ，アナトリィ　アファナシエビチ
スフホビツキィ，フラディミル　グリゴリエビチ
ミケルソン，ヤニス　マルティノビチ
ロギノフ，アナトリ　セルゲエビチ
メルニチェンコ，ナデジュダ　ティモフェエフナ
レイナサレ，ジントラ　アルフレドフナ
アルイン，レオニド　イオシフォビチ
スモトロバ，イリナ　アナトリエフナ
ソコロフ，レフ　コスンタンティノビチ
コンドラショフ，ビクトル　フラディミロビチ
ティトバ，タマラ　ミハイロフナ
セレズネバ，バレリア　エフィモフナ
マカロフ，フラディミル　アレクサンドロビチ
エルマノビチ，バレリ　フラディミロビチ
Original Assignee
フセソユズニ　ナウチノ−イススレドバテルスキ　インスティテュト　メディツィンスキフ　ポリメロフ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by フセソユズニ　ナウチノ−イススレドバテルスキ　インスティテュト　メディツィンスキフ　ポリメロフ filed Critical フセソユズニ　ナウチノ−イススレドバテルスキ　インスティテュト　メディツィンスキフ　ポリメロフ
Publication of JPH06508641A publication Critical patent/JPH06508641A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/12—Magnesium silicate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/245—Bismuth; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
JP5518208A 1992-04-10 1992-04-10 医薬組成物 Pending JPH06508641A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/RU1992/000074 WO1993020826A1 (en) 1992-04-10 1992-04-10 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
JPH06508641A true JPH06508641A (ja) 1994-09-29

Family

ID=20129712

Family Applications (1)

Application Number Title Priority Date Filing Date
JP5518208A Pending JPH06508641A (ja) 1992-04-10 1992-04-10 医薬組成物

Country Status (5)

Country Link
JP (1) JPH06508641A (es)
DE (1) DE4294862T1 (es)
GB (1) GB2272375B (es)
NL (1) NL9220019A (es)
WO (1) WO1993020826A1 (es)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11322614A (ja) * 1998-05-15 1999-11-24 Hogi Medical:Kk 細胞接着促進効果を有する創傷止血材
JP2002517284A (ja) * 1998-06-09 2002-06-18 ブリストル−マイヤーズ スクイブ カンパニー 急性創傷の治療における創傷包帯の使用
WO2004011032A1 (ja) * 2002-07-26 2004-02-05 Mikasa Seiyaku Co., Ltd. 外用剤
JP2006503044A (ja) * 2002-09-16 2006-01-26 エイジェニックス インコーポレイテッド 創傷の処置におけるラクトフェリン

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1269826B (it) * 1994-05-24 1997-04-15 Paolo Minoia Uso di antagonisti degli oppiacei e di sali di calcio per la preparazione di medicamenti per il trattamento di forme patologiche endorfino-mediate
SE507682C2 (sv) * 1996-03-29 1998-07-06 Marcin Krotkiewski Farmaceutisk beredning för behandling av gastrit, refluxesofagit, duodenit, dyspepsi och magsårssjukdom innehållande en blandning av ammoniumvismutcitrat och ett alginat
CN104383542B (zh) 2003-04-08 2017-09-26 普罗热尼奇制药公司 包含甲基纳曲酮的药物配方
AR057035A1 (es) 2005-05-25 2007-11-14 Progenics Pharm Inc SíNTESIS DE (R)-N-METILNALTREXONA, COMPOSICIONES FARMACÉUTICAS Y USOS
AR057325A1 (es) 2005-05-25 2007-11-28 Progenics Pharm Inc Sintesis de (s)-n-metilnaltrexona, composiciones farmaceuticas y usos
MX2009010515A (es) 2007-03-29 2009-10-19 Wyeth Corp Antagonistas del receptor opioide periferico y usos de los mismos.
MX2009010552A (es) 2007-03-29 2009-12-14 Progenics Pharm Inc Antagonistas de receptor de opioide periferico y usos de los mismos.
AU2008233133B2 (en) 2007-03-29 2014-03-27 Progenics Pharmaceuticals, Inc. Crystal forms of (R) -N-methylnaltrexone bromide and uses thereof
KR101581480B1 (ko) 2008-02-06 2015-12-30 프로제닉스 파머슈티컬스, 인코포레이티드 (ｒ),(ｒ)-2,2'-비스-메틸날트렉손의 제조법 및 용도
CA2676881C (en) 2008-09-30 2017-04-25 Wyeth Peripheral opioid receptor antagonists and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4391799A (en) * 1980-02-15 1983-07-05 The United States Of America As Represented By The Secretary Of The Army Protective gel composition for treating white phosphorus burn wounds
DE3686361T3 (de) * 1985-06-13 2003-01-09 Barry James Marshall Verwendung von Bismuth zur Herstellung von Medikamenten zur Behandlung von Magen-Darmstörungen, die von Campylobacter polyridis verursacht sind.
US4935406A (en) * 1988-09-20 1990-06-19 Marion Laboratories, Inc. Use of bismuth (phosph/sulf)ated saccharides against Camplyobacter-associated gastrointestinal disorders

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11322614A (ja) * 1998-05-15 1999-11-24 Hogi Medical:Kk 細胞接着促進効果を有する創傷止血材
JP2002517284A (ja) * 1998-06-09 2002-06-18 ブリストル−マイヤーズ スクイブ カンパニー 急性創傷の治療における創傷包帯の使用
WO2004011032A1 (ja) * 2002-07-26 2004-02-05 Mikasa Seiyaku Co., Ltd. 外用剤
JP2006503044A (ja) * 2002-09-16 2006-01-26 エイジェニックス インコーポレイテッド 創傷の処置におけるラクトフェリン
US8030272B2 (en) 2002-09-16 2011-10-04 Agennix Incorporated Lactoferrin compositions and methods of wound treatment
US8247373B2 (en) 2002-09-16 2012-08-21 Agennix Incorporated Lactoferrin compositions and methods of wound treatment

Also Published As

Publication number Publication date
GB2272375B (en) 1996-02-14
WO1993020826A1 (en) 1993-10-28
NL9220019A (nl) 1994-04-05
DE4294862T1 (de) 1994-06-09
GB9325480D0 (en) 1994-03-09
GB2272375A (en) 1994-05-18

Similar Documents

Publication Publication Date Title
Moncrief et al. Use of topical antibacterial therapy in the treatment of the burn wound
RU2392926C2 (ru) Оральная композиция для абсорбции фосфорных соединений
JPH06508641A (ja) 医薬組成物
JP6831227B2 (ja) 有害な微生物を阻害する方法及びそのためのバリア形成組成物
JPH07504171A (ja) Ｈ．ｐｙｌｏｒｉ及び皮膚炎の治療方法および組成物
EA008612B1 (ru) Способ лечения обычной простуды, аллергического ринита и инфекций дыхательных путей
JPS6248624A (ja) 胃腸疾患の治療用医薬組成物
TWI378797B (es)
Adewoye et al. Anti-ulcerogenic mechanism of magnesium in indomethacin induced gastric ulcer in rats
US20170172960A1 (en) Pharmaceutical formulations for treating kidney stones and methods for fabricating and using thereof
Murphy et al. Use of a high-molecular-weight carboxymethylcellulose in a tissue protective solution for prevention of postoperative abdominal adhesions in ponies
JPS62161726A (ja) 胃腸障害の治療及び予防のためのニトロフラントインの使用
WO2017060821A1 (en) Hemostatic composition
US10080728B2 (en) Hemostatic agent
EA010241B1 (ru) Фармацевтические композиции, содержащие аскорбиновую кислоту, для лечения вагинальных грибковых заболеваний
IL101739A (en) Pharmaceutical compositions comprising alginic acid and a metal compound for use in the treatment of gastroenteritic diseases wounds and burns as well as a hemostatic agent
JP3552168B2 (ja) 有効成分としてリン酸ヒスタミンを用いて損傷組織を局所的に治療するための方法および組成物
RU2139060C1 (ru) Комплексный биологически активный препарат
US20040204493A1 (en) Carbonic anhydrase inhibitors as drugs to eradicate Helicobacter pylori in the mammalian, including human, stomach
RU2288709C2 (ru) Способ повышения жизнеспособности тканей маргинальной десны при заболеваниях пародонта
AU2006285404B2 (en) Composition and method for treating nosebleeds
KR960015954B1 (ko) 위장질환 치료제
Bahrawy et al. Abeer S. Gawish, A Mai S. Attia, A, B Dina A. Osman, C
Anyanechi et al. Clinical evaluation of the efficacy of arthocare forte, a chondro-protective and anti-arthritic drug in the management of bacterial plaque-induced chronic periodontitis
Issrani et al. Exploring the properties of formocresol in dentistry---a comprehensive review.